• Sanchia Aranda, Seth Berkley, Sally Cowal, Mark Dybul, Tim Evans, Katja Iversen, Matshidiso Moeti, Babatunde Osotimehin, Stefan Peterson, Peter Piot, Chittaranjan N Purandare, Michel Sidibé, Ted Trimble, and TsuVivien DavisVDPATH, Seattle, WA, USA..
• Union for International Cancer Control, Geneva, Switzerland.
• Int J Gynaecol Obstet. 2017 Jul 1; 138 Suppl 1: 4-6.

AbstractThe outlook for elimination of the scourge of cervical cancer is bright, because we now have the tools to achieve this goal. In recent years human papillomavirus (HPV) vaccination in high-income countries has resulted in dramatic decreases in HPV infection and associated cervical disease. If all countries with a substantial burden of disease introduce the vaccine nationally, we can protect the vast majority of women and girls most at risk. For women who are beyond the vaccination target age, progress has been made in screening and treatment for cervical precancer, but we must accelerate this momentum to reduce incidence and mortality worldwide to the very low rates found in wealthier countries. Human and financial resources must be increased and directed to programs that follow best practices and reach all women, including the marginalized or disadvantaged. Seven key actions are recommended. Now is the time for action at national, regional, and global levels.© 2017 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.

17 keywords...

hide…